Phase I study of L-asparaginase encapsulated in red blood cells (ERYASP) in comb with CALGB regimen during induction and consolidation phases for frontline therapy, patients older than 40 years with Philadelphia chromosome-negative ALL

Administered By

Awarded By

Contributors

Start/End

  • March 1, 2014 - December 17, 2018